Age at Menopause and Development of Type 2 Diabetes in Korea

被引:0
|
作者
Ko, Byung-Joon [3 ]
Jung, Jin-Hyung [4 ]
Han, Kyungdo [2 ]
Nam, Ga Eun [1 ]
机构
[1] Korea Univ, Guro Hosp, Coll Med, Dept Family Med, 148 Gurodong Ro, Seoul 08308, South Korea
[2] Soongsil Univ, Dept Stat & Actuarial Sci, 369 Sangdo Ro, Seoul 06978, South Korea
[3] Joon 365 Clin, Hwaseong, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon, South Korea
基金
新加坡国家研究基金会;
关键词
NATURAL MENOPAUSE; RISK; ASSOCIATION; WOMEN;
D O I
10.1001/jamanetworkopen.2024.55388
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ImportanceThere is limited evidence regarding the association between age at menopause and incident type 2 diabetes (T2D). ObjectiveTo investigate whether age at menopause and premature menopause are associated with T2D incidence in postmenopausal Korean women. Design, Setting, and ParticipantsThis population-based cohort study was conducted among a nationally representative sample from the Korean National Health Insurance Service database of 1 125 378 postmenopausal women without T2D who enrolled in 2009. The median (IQR) follow-up was 8.4 (8.1-8.7) years. Data were analyzed in March 2024. ExposuresAge at menopause and premature menopause (menopause onset at age <40 years). Main Outcomes and MeasuresThe primary outcome was incident T2D. Multivariable Cox proportional hazards regression analysis was used to estimate hazard ratios (HRs) and 95% CIs for incident T2D by age at menopause, adjusting for potential confounders. ResultsOf 1 125 378 participants (mean [SD] age at enrollment, 61.2 [8.4] years), 113 864 individuals (10.1%) were diagnosed with T2D at least 1 year after enrollment. Women with menopause onset at ages younger than 40 years (premature menopause; HR, 1.13; 95% CI, 1.08-1.18) and ages 40 to 44 years (HR, 1.03; 95% CI, 1.00-1.06) had increased risk of T2D compared with those with onset at age 50 years or older, with adjustment for sociodemographic, lifestyle, cardiometabolic, psychiatric, and reproductive factors; a younger age at menopause was associated with increased risk of developing T2D (P for trend <.001). Body mass index, depressive disorder, and prediabetes modified the association in subgroup analyses; for example, for individuals with premature menopause vs those with menopause at ages 50 years or older, HRs were 1.54 (95% CI, 1.14-2.06) for a BMI less than 18.5 and 1.14 (95% CI, 1.00-1.30) for a BMI of 30 or greater (P < .001), 1.28 (95% CI, 1.12-1.45) for individuals with depression and 1.11 (95% CI, 1.07-1.16) for those without depression (P = .01), and 1.25 (95% CI, 1.18-1.33) for individuals who were not prediabetic and 1.04 (95% CI, 0.99-1.11) those who were prediabetic (P < .001). Conclusions and RelevanceIn this study, premature and early menopause were associated with a higher risk of T2D, highlighting the need for targeted public health strategies aimed at preventing or delaying T2D among postmenopausal women.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Association of age at menopause with type 2 diabetes mellitus in postmenopausal women: a systematic review and meta-analysis
    Zakerinasab, Faezeh
    Al Saraireh, Taif Haiham
    Amirbeik, Amirhesam
    Zadeh, Rasoul Hossein
    Mojeni, Fariba Arbab
    Behfar, Qumars
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2024, 23 (04): : 207 - 215
  • [22] Association of age at diabetes complication diagnosis with age at natural menopause in women with type 1 diabetes: The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study
    Yi, Yan
    El Khoudary, Samar R.
    Buchanich, Jeanine M.
    Miller, Rachel G.
    Rubinstein, Debra
    Orchard, Trevor J.
    Costacou, Tina
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (03)
  • [23] Menopause in women with type 1 diabetes
    Sjoberg, Lena
    Pitkaniemi, Janne
    Harjutsalo, Valma
    Haapala, Laura
    Tiitinen, Aila
    Tuomilehto, Jaakko
    Kaaja, Risto
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2011, 18 (02): : 158 - 163
  • [24] Menopause in women with type 1 diabetes
    Sjoberg, L.
    Haapala, L.
    Harjutsalo, V.
    Pitkaniemi, I.
    Tuomilehto, J.
    Kaaja, R.
    DIABETOLOGIA, 2008, 51 : S158 - S158
  • [25] Menopause in women with type 1 diabetes
    Costacou, Tina
    Orchard, Trevor J.
    DIABETES, 2007, 56 : A270 - A270
  • [26] Therapeutic effects of glimepride on type 2 diabetes in Korea
    Hyunchul, L
    DIABETES MELLITUS: RECENT ADVANCES FOR THE 21ST CENTURY, 2000, 1209 : 51 - 54
  • [27] Therapeutic strategies for type 2 diabetes mellitus in women after menopause
    Paschou, Stavroula A.
    Marina, Ljiljana, V
    Spartans, Eleftherios
    Anagnostis, Panagiotis
    Alexandrou, Andreas
    Goulis, Dimitrios G.
    Lambrinoudaki, Irene
    MATURITAS, 2019, 126 : 69 - 72
  • [28] Development and validation of a computerized exercise intervention program for patients with type 2 diabetes mellitus in Korea
    Yoo, JS
    Hwang, AR
    Lee, HC
    Kim, CJ
    YONSEI MEDICAL JOURNAL, 2003, 44 (05) : 892 - 904
  • [29] Association of age at menopause and type 2 diabetes: A systematic review and dose-response meta-analysis of cohort studies
    Guo, Chunmei
    Li, Quanman
    Tian, Gang
    Liu, Yu
    Sun, Xizhuo
    Yin, Zhaoxia
    Li, Honghui
    Chen, Xu
    Liu, Xuejiao
    Zhang, Dongdong
    Cheng, Cheng
    Liu, Leilei
    Liu, Feiyan
    Zhou, Qionggui
    Wang, Chongjian
    Li, Linlin
    Wang, Bingyuan
    Zhao, Yang
    Liu, Dechen
    Zhang, Ming
    Hu, Dongsheng
    PRIMARY CARE DIABETES, 2019, 13 (04) : 301 - 309
  • [30] Age at menarche and age at natural menopause as predictors of glycemic control in type 2 diabetic patients
    Shen, Chong
    Wen, Jinbo
    Pan, Xiaoqun
    Su, Jian
    Du, Wencong
    Pan, Enchun
    Zhang, Qin
    Zhang, Ning
    Sheng, Hongyan
    Liu, Chunlan
    Wang, Hui
    Wu, Ming
    Qin, Yu
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (07) : 623 - 629